A Phase 1 interventional study of Placebo and Bacopa Monnieri 300 mg/day in Healthy, sponsored by Khon Kaen University. Completed at 1 site in Thailand. Open to participants aged 15 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-08-18.
Sponsored by Khon Kaen University · Phase 1, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to determine the effect of Bacopa Monnieri on working memory and cognitive processing in student.
Learning and working memory are two of the key role for studying and work successful for student particular the high school student who study hard and preparing themselves for the graduate study. The consumption of brain booster product or functional food for improving memory has gained much attention. It has been reported that Bacopa Monnieri could improve learning and working memory in elderly subject by improving the N100 and P300 event related potential. Therefore, Bacopa Monnieri might be the potential product for improving the learning and working memory in student particular high school student.
Khon Kaen University is the lead sponsor of 161 studies on the registry; 24 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects are received the pill of placebo which has same color, shape and smell like the Bacopa Monnieri once daily for 16 weeks.
Dietary Supplement: Placebo
Subjects are received the pill of Bacopa Monnieri at the dose of 300 mg/day once daily for 16 weeks
Dietary Supplement: Bacopa Monnieri 300 mg/day
Subjects are received the pill of Bacopa Monnieri at the dose of 600 mg/day once daily for 16 weeks
Dietary Supplement: Bacopa Monnieri 600 mg/day
Subjects are received Placebo once daily for 16 weeks.
Drug page: Bacopa monnieriStudies of Bacopa monnieriBacopa monnieri pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
Subjects are received Bacopa Monnieri at the dose of 300 mg/day once daily for 16 weeks.
Drug page: Bacopa monnieriStudies of Bacopa monnieriBacopa monnieri pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.
Subjects are received Bacopa Monnieri at the dose of 600 mg/day once daily for 16 weeks.
Cognitive processing using the latency of P300 wave
The latency of P300 wave was measured and expressed as millisecond.
Time frame: 4 months
Cognitive processing using the amplitude of P300 wave
The amplitude of P300 wave was measured and expressed as micro-volt.
Time frame: 4 months
Attention using the latency of N100 wave
The latency of N100 wave was measured and expressed as millisecond.
Time frame: 4 months
Attention using the amplitude of N100 wave
The amplitude of N100 wave was measured and expressed as micro-volt.
Time frame: 4 months
Accuracy of working memory using computerized battery test
The accuracy of working memory was determined and expressed as percentage.
Time frame: 4 months
Speed of working memory using computerized battery test
The speed of working memory was determined and expressed as millisecond.
Time frame: 4 months
Assessment of psychiatric symptoms using the symptom check list 90 (SCL-90)
Time frame: 4 months
Assessment of mood scale using Bond-Lader visual analogue scales
Time frame: 4 months
Acetylcholinesterase activity in serum
Time frame: 4 months
Monoamine oxidase activity in serum
Time frame: 4 months
Glutamic acid decarboxylase (GAD) activity in serum
Time frame: 4 months
Gamma-aminobutyric acid (GABA)-transaminase in serum
Time frame: 4 months
Malondialdehyde level in serum
Time frame: 4 months
Activity of superoxide dismutase in serum
Time frame: 4 month
Activity of catalase in serum
Time frame: 4 month
Activity of glutathione peroxidase in serum
Time frame: 4 month
Consumption safety of Bacopa Monnieri using electrocardiogram (EKG)
Time frame: 4 month
Consumption safety of Bacopa Monnieri using hematological values .
The hematological values including red blood cell, white blood cell, hematocrit and platelet were determined and the data was expressed as number of subject presented with abnormal hematological value.
Time frame: 4 month
Consumption safety of Bacopa Monnieri using blood chemistry
The blood chemistry values including renal function test, liver function test, lipid profile, electrolytes and glucose were determined and the data was expressed as number of subject presented with abnormal blood chemistry value.
Time frame: 4 month
Consumption safety of Bacopa Monnieri using blood pressure measurement
Time frame: 4 month
Plan to share: No
No publications or documents are linked to this record.
The record gives a start of Jul 2016, a primary completion of Mar 2017 and a completion of Mar 2017. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Bacopa monnieri